Our study uncovered that murine MYC tumors exhibit subclones that are distinct from other tumor subpopulations and express epigenetic modifiers like Dnmt1 or Ezh2. In addition, these epigenetically-driven subclones are mitotically active and express genes that are related to aurora signaling, DNA repair and telomere maintenance. The gene discussed is DNMT1; the disease is neoplasm.